Reblozyl (luspatercept)

luspatercept · Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Reblozyl (luspatercept), covering 2025-08-05 to 2025-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients [Phase 1, Phase 2]